Inflammatory bowel disease (IBD) is characterised by an inappropriate chronic immune response against resident gut microbes. This may be on account of distinct changes in the gut microbiota termed as dysbiosis. The role of fungi in this altered luminal environment has been scarcely reported. We studied the fungal microbiome in de-novo paediatric IBD patients utilising next generation sequencing and compared with adult disease and normal controls. We report a distinct difference in fungal species with Ascomycota predominating in control subjects compared to Basidiomycota dominance in children with IBD, which could be as a result of altered tolerance in these patients. (C) 2015 The Authors. Published by Elsevier Masson SAS on behalf of Institut Pasteur.
|Number of pages||7|
|Journal||Microbes and Infection|
|Early online date||15 Dec 2014|
|Publication status||Published - Apr 2015|
- fungal microbiota
- paediatric inflammatory bowel disease
- gut microbiota
FingerprintDive into the research topics of 'The fungal microbiota of de-novo paediatric inflammatory bowel disease'. Together they form a unique fingerprint.